Mostrar el registro sencillo del ítem
Paciente femenino de 60 años con diagnóstico de fibrosis pulmonar.
| dc.contributor.advisor | Martínez Mora, Stalin Fabián | |
| dc.contributor.author | Cedeño Bermudes, Kevin Richard | |
| dc.date.accessioned | 2021-10-19T18:50:37Z | |
| dc.date.available | 2021-10-19T18:50:37Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/10225 | |
| dc.description | Pulmonary fibrosis is nothing more than a disease that affects the lower respiratory tract, the main characteristic of which is the scarring of the lung tissues, thus considerably reducing the normal passage of air into the blood. Its main symptoms include dyspnea, dry cough and chest pain. The main objective of the treatment we apply to patients with pulmonary fibrosis is to improve, reduce symptoms, and slow down the progression of the disease. Among the main risk factors is sex since it affects the male sex more, and it is generally diagnosed more from 50 to 80 years of age. | es_ES |
| dc.description | Pulmonary fibrosis is nothing more than a disease that affects the lower respiratory tract, the main characteristic of which is the scarring of the lung tissues, thus considerably reducing the normal passage of air into the blood. Its main symptoms include dyspnea, dry cough and chest pain. The main objective of the treatment we apply to patients with pulmonary fibrosis is to improve, reduce symptoms, and slow down the progression of the disease. Among the main risk factors is sex since it affects the male sex more, and it is generally diagnosed more from 50 to 80 years of age. | es_ES |
| dc.description.abstract | La fibrosis pulmonar no es otra cosa que una enfermedad que la afecta las vías respiratorias inferiores cuya principal característica es la cicatrización de los tejidos pulmonares de esta manera se reduce considerablemente el paso normal del aire hacia la sangre. Entre sus principales síntomas están disnea, tos seca y dolor precordial. El objetivo principal del tratamiento que aplicamos a los pacientes con fibrosis pulmonar es el de mejorar, disminuir los síntomas, y enlentecer el avance de la enfermedad. Entre los principales factores de riesgo está el sexo ya que afecta más al sexo masculino, y por lo general se diagnostica más a partir de los 50 a 80 años. | es_ES |
| dc.format.extent | 28 p | es_ES |
| dc.language.iso | es | es_ES |
| dc.publisher | Babahoyo: UTB-FCS, 2021 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
| dc.subject | Fibrosis Pulmonar | es_ES |
| dc.subject | Disnea | es_ES |
| dc.subject | Sangre | es_ES |
| dc.subject | Radiografía | es_ES |
| dc.title | Paciente femenino de 60 años con diagnóstico de fibrosis pulmonar. | es_ES |
| dc.type | bachelorThesis | es_ES |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 Ecuador